Javascript must be enabled to continue!
MO667: Creating a New Cardiorenal Unit: 3-Year Study Results
View through CrossRef
Abstract
BACKGROUND AND AIMS
Cardiorenal syndrome is a clinical manifestation of the bidirectional interaction between the heart and kidney diseases, so creating specific units between cardiologists and nephrologists is necessary for better treatment of these patients.
In our hospital we have recently formed a workgroup for better organization of patients who need peritoneal dialysis (PD) and day-hospital assistant.
The aim of this study is to analyse the evolution of the patients in our PD program since the creation of a new cardiorenal unit in our center.
METHOD
This study includes patients beginning PD due to cardiorenal syndrome since the creation of our cardiorenal unit, between 15 June 2018 and 14 June 2021. We have registered the date of PD initiation and also the date of exclusion of the technique. Also we performed a pre–post observational study comparing the number of hospitalizations/emergency visits in the year before PD starts and its evolution for the next year. Statistical study was analysed with SPSS software, for a P-value <0.05.
RESULTS
Twelve patients (9 men and 3 women) have been included in this study. The mean age was 66.50 years (range 50–82). PD survival was 34.43 months (range 7–70). The number of hospitalizations/emergency visits was 8.04 in the year before PD started, and 0.44 the next year (P < 0.05). Nine of 12 patients had zero hospitalizations in the 12 months after initiating PD.
CONCLUSION
PD is an interesting treatment option for patients with cardiorenal diseases, which allows a significant reduction in hospitalization and decompensation rates. Creating new cardiorenal units is a good option for the integral management of these patients.
Title: MO667: Creating a New Cardiorenal Unit: 3-Year Study Results
Description:
Abstract
BACKGROUND AND AIMS
Cardiorenal syndrome is a clinical manifestation of the bidirectional interaction between the heart and kidney diseases, so creating specific units between cardiologists and nephrologists is necessary for better treatment of these patients.
In our hospital we have recently formed a workgroup for better organization of patients who need peritoneal dialysis (PD) and day-hospital assistant.
The aim of this study is to analyse the evolution of the patients in our PD program since the creation of a new cardiorenal unit in our center.
METHOD
This study includes patients beginning PD due to cardiorenal syndrome since the creation of our cardiorenal unit, between 15 June 2018 and 14 June 2021.
We have registered the date of PD initiation and also the date of exclusion of the technique.
Also we performed a pre–post observational study comparing the number of hospitalizations/emergency visits in the year before PD starts and its evolution for the next year.
Statistical study was analysed with SPSS software, for a P-value <0.
05.
RESULTS
Twelve patients (9 men and 3 women) have been included in this study.
The mean age was 66.
50 years (range 50–82).
PD survival was 34.
43 months (range 7–70).
The number of hospitalizations/emergency visits was 8.
04 in the year before PD started, and 0.
44 the next year (P < 0.
05).
Nine of 12 patients had zero hospitalizations in the 12 months after initiating PD.
CONCLUSION
PD is an interesting treatment option for patients with cardiorenal diseases, which allows a significant reduction in hospitalization and decompensation rates.
Creating new cardiorenal units is a good option for the integral management of these patients.
Related Results
Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies
Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies
Objective
To review the current knowledge about the pathophysiological mechanisms, preclinical models, novel contributors and potential therapies of cardiorenal syndrom...
Roles for SGLT2 Inhibitors in Cardiorenal Disease
Roles for SGLT2 Inhibitors in Cardiorenal Disease
<b><i>Introduction:</i></b> Cardiovascular (CV) disease and chronic kidney disease (CKD) share common risk factors, including type 2 diabetes mellitus (T2D...
Integrated Cardiorenal Risk in Multimorbidity: Emerging Biomarkers, Prognostic Stratification, and Contemporary Therapeutic Strategies
Integrated Cardiorenal Risk in Multimorbidity: Emerging Biomarkers, Prognostic Stratification, and Contemporary Therapeutic Strategies
Cardiorenal syndrome represents a complex clinical condition resulting from bidirectional interactions between cardiac and renal dysfunction and is particularly relevant in patient...
Secondary Cardiorenal Syndromes in Children: Focus on Type 3 to 5 Cardiorenal Syndrome
Secondary Cardiorenal Syndromes in Children: Focus on Type 3 to 5 Cardiorenal Syndrome
Background: The interaction between the heart and kidneys involves complex mechanisms, leading to a clinical condition known as cardiorenal syndrome (CRS), where dysfunction in one...
Analisis Asuhan Keperawatan Pada Pasien Chronic Kidney Disease Dengan Cardiorenal Syndrome di Ruang Intensif Care Unit
Analisis Asuhan Keperawatan Pada Pasien Chronic Kidney Disease Dengan Cardiorenal Syndrome di Ruang Intensif Care Unit
Penyakit ginjal dan jantung merupakan penyakit yang memiliki tingkat morbiditas dan mortalitas yang tinggi. Organ ginjal dan jantung memiliki faktor risiko vaskular yang sama dan s...
Inseparable in Disease, Yet Treated Apart: A Retrospective Study of a Cardiorenal Cohort at a Tertiary University Hospital
Inseparable in Disease, Yet Treated Apart: A Retrospective Study of a Cardiorenal Cohort at a Tertiary University Hospital
Introduction: The prevalence of cardiorenal syndrome (CRS) and its management might be challenging, so an interdisciplinary approach is advocated. The aim of this study was to iden...
Sistem Antrian Kendaraan Angkutan Barang pada Unit Pelaksana Penimbangan Kendaraan Bermotor Kayumalue
Sistem Antrian Kendaraan Angkutan Barang pada Unit Pelaksana Penimbangan Kendaraan Bermotor Kayumalue
Abstract. The high arrival flow of freight vehicles at Kayumalue Motor Vehicle Weighing Implementation Unit at certain times causes queues. The purpose of this study was to determi...
Higenamine Improves Cardiac and Renal Fibrosis in Rats With Cardiorenal Syndrome via ASK1 Signaling Pathway
Higenamine Improves Cardiac and Renal Fibrosis in Rats With Cardiorenal Syndrome via ASK1 Signaling Pathway
Abstract:
The pathogenesis of cardiorenal syndrome (CRS) is very complex, and currently there is no effective treatment for CRS. Higenamine (HI) has been shown to improve...

